Endovascular Treatment Versus Best Medical Management in Acute Basilar Artery Occlusion Strokes: Results From the ATTENTION Multicenter Registry.
Tao C, Qureshi AI, Yin Y, Li J, Li R, Xu P, Sun J, Liao G, Yue X, Shi H, Liu Y, Ma Z, Zhang J, Xiao G, Xu B, Xu C, Su J, Zhou W, Huang S, Yang W, Chen H, Li W, Li Y, Liu D, Yu C, Yuan G, Wang C, Liang W, Chen C, Shi X, Wang J, Wu Y, Cai X, Shen C, Li K, Fang P, Wang M, Chen Z, Li T, Cheng G, Sun Y, Wang Y, Zhang H, Chen J, Xu X, Wang Y, Geng W, Ni C, Chen C, Liu Y, Min J, Zhang Y, Liang Y, Wen C, Baxter BW, Nogueira RG, Hu W; ATTENTION (Endovascular Treatment for Acute Basilar Artery Occlusion) Trial Investigators.
Tao C, et al.
Circulation. 2022 Jul 5;146(1):6-17. doi: 10.1161/CIRCULATIONAHA.121.058544. Epub 2022 Jun 3.
Circulation. 2022.
PMID: 35656816
Qualifying patients had to present within 24 hours of estimated BAO. The primary clinical outcome was favorable functional outcome (modified Rankin Scale score, 0-3) at 90 days. ...Well-designed randomized studies comparing EVT with BMM in the acute BAO are needed. …
Qualifying patients had to present within 24 hours of estimated BAO. The primary clinical outcome was favorable functional outcome (m …